Bioverativ: More Than Just A Hemophilia Company

John Cox at JPM
Bioverativ CEO John Cox
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business